Sarah Benghanem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Sarah Benghanem has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Alain Cariou
11 shared publicationsEstelle Pruvost-Robieux
8 shared publications- Bertrand Hermann
Université Paris Cité, Institute of Psychiatry and Neurosciences of Paris (IPNP), INSERM U1266, Stroke Team, Paris, France
6 shared publications Martine Gavaret
Medical school, Sorbonne University, Paris, France
6 shared publications- Tarek Sharshar
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team6 Turc, 75014 Paris, France
6 shared publications - Alain Cariou
Cochin University Hospital (AP-HP) and University Paris Cité (Medical School), Paris, France
5 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Taylor & Francis in Medical Education Online
- Vol. 31 (1)
Training of trainers on medical education reforms: a prospective multicenter French survey among intensivists
- 22 July 2026
- Published by Taylor & Francis in Medical Education Online
- Vol. 31 (1)
Open AccessTraining of trainers on medical education reforms: a prospective multicenter French survey among intensivists
- 2 July 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1826
Publisher Correction: Current knowledge and challenges of sepsis-associated encephalopathy
- 2 July 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1826
Publisher Correction: Current knowledge and challenges of sepsis-associated encephalopathy
- Top Cited Papers
- 16 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1-18
Current knowledge and challenges of sepsis-associated encephalopathy
Encephalopathy is a common complication of sepsis, occurring in up to 70% of patients admitted to the intensive care unit. It is primarily characterized by
- 16 June 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (8) , 1-18
Top Cited PapersCurrent knowledge and challenges of sepsis-associated encephalopathy
Encephalopathy is a common complication of sepsis, occurring in up to 70% of patients admitted to the intensive care unit. It is primarily characterized by
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Sons à valence émotionnelle et évaluation du pronostic neurologique des patients cérébrolésés en soins critiques
L'évaluation du pronostic neurologique des patients inconscients en réanimation constitue un enjeu majeur médical et éthique. Ces troubles de conscience sont majoritairement liés à une agression cérébrale post-arrêt cardiaque, traumatique ou vasculaire. Les techniques actuellement disponibles neurophysiologiques (électroencéphalogramme - EEG et potentiels évoqués - PE), neuroradiologiques ou biologiques ne permettent qu'une évaluation approximative pour un grand nombre de patients. Dans ce contexte, de nouveaux marqueurs pronostiques sont nécessaires. Les potentiels évoqués auditifs tardifs (PEAT) semblent être une méthode prometteuse. Lors de leurs réalisations (exposition du sujet à l'écoute d'un stimulus auditif déviant au sein d'autres stimuli fréquent), une première réponse appelée « mismatch negativity » - MMN est générée, puis une deuxième réponse P300 est observée. Ces deux réponses traduisent l'orientation de l'attention du sujet vers le stimulus déviant et pourraient être prédictive de l'éveil chez des patients inconscients. La réponse P300 obtenue en exposant le sujet à son propre prénom semble améliorer sa valeur pronostique. De plus, l'utilisation d'un stimulus « propre prénom » prononcé par une voix familière (VF) comparé à une voix non familière (VNF) pourrait encore améliorer la valeur pronostique de la P300. En effet, le traitement neuronal des voix expressives mobilise des circuits de réponse plus variés comparé aux voix neutres. Par ailleurs, il semble que certains sons présentant des modifications dynamiques (sons « approchants » appelés looming ou s'éloignant du sujet, appelés receding), pourrait constituer un signal d'alarme élémentaire pour l'Homme, capable de susciter des réponses adaptatives en mobilisant des ressources attentionnelles supplémentaires. Ainsi, l'utilisation de ces sons à valence émotionnelle pourraient avoir un intérêt pour générer ces réponses MMN et P300, prédictives de l'éveil. Cette thèse se propose de caractériser les bases neurales de la modulation des réponses MMN et P300, en fonction de l'utilisation de sons neutres (P300 au prénom - VNF et MMN aux sons constants) et de sons à valence émotionnelle (P300 au prénom - VF et MMN aux sons looming et receding). Pour cela, nous avons mené trois études : 1/ Express-Healthy : cette étude prospective chez 18 sujets sains avait pour objectif d'évaluer les caractéristiques des réponses MMN induites par des modifications du stimulus déviant (looming, receding ou constant) ; Nos résultats suggèrent que les sons looming étaient à même de générer une réponse MMN plus ample et mieux reproductible, comparé aux receding et aux constants ; 2/ Express-Coma : cette étude prospective menée chez 55 patients de réanimation avait pour objectif principal d'évaluer la valeur pronostique de la réponse P300 propre prénom - VF comparée à la P300 - VNF. L'objectif secondaire était d'évaluer la valeur pronostique de la MMN générée avec des stimuli sonores dynamiques (looming, receding) comparé aux constants ; Nous avons mis en évidence que les réponses MMN et P300 étaient fortement associées au pronostic à 3 mois, quel que soit le type de stimulus (émotionnel ou neutre) utilisé; 3/ Express-Intra: cette étude prospective menée chez 15 patients implantés d'électrodes EEG en intra cérébral (stétéo-EEG) avait pour objectif d'identifier les aires cérébrales spécifiquement mises en jeu lors de l'écoute des sons looming, receding et constants. Dans cette étude, plusieurs aires temporales (en dehors du cortex auditif primaire) étaient impliquées dans l'intégration de ces sons. En conclusion, nos données suggèrent que des paradigmes auditifs utilisant des sons à valence émotionnelle pourraient être intéressants chez des patients comateux en réanimation, leur intégration nécessitant l'activation de structures cérébrales impliquées dans la reconnaissance émotionnelle d'un stimuli mais également dans la perception et la conscience du soi.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Sons à valence émotionnelle et évaluation du pronostic neurologique des patients cérébrolésés en soins critiques
L'évaluation du pronostic neurologique des patients inconscients en réanimation constitue un enjeu majeur médical et éthique. Ces troubles de conscience sont majoritairement liés à une agression cérébrale post-arrêt cardiaque, traumatique ou vasculaire. Les techniques actuellement disponibles neurophysiologiques (électroencéphalogramme - EEG et potentiels évoqués - PE), neuroradiologiques ou biologiques ne permettent qu'une évaluation approximative pour un grand nombre de patients. Dans ce contexte, de nouveaux marqueurs pronostiques sont nécessaires. Les potentiels évoqués auditifs tardifs (PEAT) semblent être une méthode prometteuse. Lors de leurs réalisations (exposition du sujet à l'écoute d'un stimulus auditif déviant au sein d'autres stimuli fréquent), une première réponse appelée « mismatch negativity » - MMN est générée, puis une deuxième réponse P300 est observée. Ces deux réponses traduisent l'orientation de l'attention du sujet vers le stimulus déviant et pourraient être prédictive de l'éveil chez des patients inconscients. La réponse P300 obtenue en exposant le sujet à son propre prénom semble améliorer sa valeur pronostique. De plus, l'utilisation d'un stimulus « propre prénom » prononcé par une voix familière (VF) comparé à une voix non familière (VNF) pourrait encore améliorer la valeur pronostique de la P300. En effet, le traitement neuronal des voix expressives mobilise des circuits de réponse plus variés comparé aux voix neutres. Par ailleurs, il semble que certains sons présentant des modifications dynamiques (sons « approchants » appelés looming ou s'éloignant du sujet, appelés receding), pourrait constituer un signal d'alarme élémentaire pour l'Homme, capable de susciter des réponses adaptatives en mobilisant des ressources attentionnelles supplémentaires. Ainsi, l'utilisation de ces sons à valence émotionnelle pourraient avoir un intérêt pour générer ces réponses MMN et P300, prédictives de l'éveil. Cette thèse se propose de caractériser les bases neurales de la modulation des réponses MMN et P300, en fonction de l'utilisation de sons neutres (P300 au prénom - VNF et MMN aux sons constants) et de sons à valence émotionnelle (P300 au prénom - VF et MMN aux sons looming et receding). Pour cela, nous avons mené trois études : 1/ Express-Healthy : cette étude prospective chez 18 sujets sains avait pour objectif d'évaluer les caractéristiques des réponses MMN induites par des modifications du stimulus déviant (looming, receding ou constant) ; Nos résultats suggèrent que les sons looming étaient à même de générer une réponse MMN plus ample et mieux reproductible, comparé aux receding et aux constants ; 2/ Express-Coma : cette étude prospective menée chez 55 patients de réanimation avait pour objectif principal d'évaluer la valeur pronostique de la réponse P300 propre prénom - VF comparée à la P300 - VNF. L'objectif secondaire était d'évaluer la valeur pronostique de la MMN générée avec des stimuli sonores dynamiques (looming, receding) comparé aux constants ; Nous avons mis en évidence que les réponses MMN et P300 étaient fortement associées au pronostic à 3 mois, quel que soit le type de stimulus (émotionnel ou neutre) utilisé; 3/ Express-Intra: cette étude prospective menée chez 15 patients implantés d'électrodes EEG en intra cérébral (stétéo-EEG) avait pour objectif d'identifier les aires cérébrales spécifiquement mises en jeu lors de l'écoute des sons looming, receding et constants. Dans cette étude, plusieurs aires temporales (en dehors du cortex auditif primaire) étaient impliquées dans l'intégration de ces sons. En conclusion, nos données suggèrent que des paradigmes auditifs utilisant des sons à valence émotionnelle pourraient être intéressants chez des patients comateux en réanimation, leur intégration nécessitant l'activation de structures cérébrales impliquées dans la reconnaissance émotionnelle d'un stimuli mais également dans la perception et la conscience du soi.
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214690
Value of Isolated vs Multiple Malignant EEG Criteria to Reduce Prognostic Uncertainty in Comatose Patients After Cardiac Arrest
- 24 February 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (4) , e214690
Value of Isolated vs Multiple Malignant EEG Criteria to Reduce Prognostic Uncertainty in Comatose Patients After Cardiac Arrest
- 23 December 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (12) , e214426
Value of Isolated vs Multiple Malignant EEG Criteria to Reduce Prognostic Uncertainty in Comatose Patients After Cardiac Arrest
In comatose patients after cardiac arrest (CA), only "highly malignant" or "benign" EEG patterns are recognized as robust markers of poor and good outcomes, respectively, whereas many patients with "malignant" EEG remain in prognostic uncertainty. We aimed to assess the prognostic value of combined malignant EEG criteria for poor neurologic outcome in this clinical setting and to evaluate their effect on reduction of prognostic uncertainty. We conducted a bicentric cohort study using institutional registries (CHUV, Switzerland; Cochin Hospital, France), including comatose adults who underwent EEG >24 hours after CA. EEGs were categorized according to Westhall et al.: highly malignant, malignant, or benign. We assessed the prognostic performance of isolated and combined malignant EEG criteria (recorded on a single EEG after targeted temperature management) and their ability to reduce prognostic uncertainty in patients with an "indeterminate prognosis" according to current European recommendations. Poor neurologic outcome was defined as a Cerebral Performance Category 3-5 at 3 months. Between 2017 and 2024, 1,076 patients were included (CHUV: 655; Cochin: 421). The mean age was 61.7 (SD ± 15.2) years, and 291 (27.2%) were female; 633 (59.5%) died while 317 (29.5%) had a good outcome. EEG was highly malignant in 23.6%, malignant in 39.1%, and benign in 36.8%. One malignant EEG feature predicted poor outcome (specificity 81.4% [95% CI 77.10-85.67]), sensitivity 24.2% ([95% CI 21.19-27.29]). Two, 3, or 4 malignant EEG criteria were highly specific (98.1% ([95% CI 96.61-99.61], 100% [95% CI 100.00-100.00], and 100% [95% CI 100.00-100.00], respectively), with limited sensitivity (16.9% [95% CI 14.20-19.53], 4.6% [95% CI 3.12-6.10], and 0.4% [95% CI 0.00-0.84]). Among the 725 lacking 2 criteria for poor outcome according to recommendations, 386 had a benign EEG, leaving 339 in the indeterminate outcome group. Among these, multiple malignant EEG features reclassified 106 patients into the "likely poor outcome" category, reducing prognostic uncertainty by 31.3%. The combination of multiple malignant EEG criteria seems to be as specific as a highly malignant EEG in predicting poor neurologic outcome. Using these criteria significantly reduces prognostic uncertainty.
- 23 December 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 105 (12) , e214426
Value of Isolated vs Multiple Malignant EEG Criteria to Reduce Prognostic Uncertainty in Comatose Patients After Cardiac Arrest
In comatose patients after cardiac arrest (CA), only "highly malignant" or "benign" EEG patterns are recognized as robust markers of poor and good outcomes, respectively, whereas many patients with "malignant" EEG remain in prognostic uncertainty. We aimed to assess the prognostic value of combined malignant EEG criteria for poor neurologic outcome in this clinical setting and to evaluate their effect on reduction of prognostic uncertainty. We conducted a bicentric cohort study using institutional registries (CHUV, Switzerland; Cochin Hospital, France), including comatose adults who underwent EEG >24 hours after CA. EEGs were categorized according to Westhall et al.: highly malignant, malignant, or benign. We assessed the prognostic performance of isolated and combined malignant EEG criteria (recorded on a single EEG after targeted temperature management) and their ability to reduce prognostic uncertainty in patients with an "indeterminate prognosis" according to current European recommendations. Poor neurologic outcome was defined as a Cerebral Performance Category 3-5 at 3 months. Between 2017 and 2024, 1,076 patients were included (CHUV: 655; Cochin: 421). The mean age was 61.7 (SD ± 15.2) years, and 291 (27.2%) were female; 633 (59.5%) died while 317 (29.5%) had a good outcome. EEG was highly malignant in 23.6%, malignant in 39.1%, and benign in 36.8%. One malignant EEG feature predicted poor outcome (specificity 81.4% [95% CI 77.10-85.67]), sensitivity 24.2% ([95% CI 21.19-27.29]). Two, 3, or 4 malignant EEG criteria were highly specific (98.1% ([95% CI 96.61-99.61], 100% [95% CI 100.00-100.00], and 100% [95% CI 100.00-100.00], respectively), with limited sensitivity (16.9% [95% CI 14.20-19.53], 4.6% [95% CI 3.12-6.10], and 0.4% [95% CI 0.00-0.84]). Among the 725 lacking 2 criteria for poor outcome according to recommendations, 386 had a benign EEG, leaving 339 in the indeterminate outcome group. Among these, multiple malignant EEG features reclassified 106 patients into the "likely poor outcome" category, reducing prognostic uncertainty by 31.3%. The combination of multiple malignant EEG criteria seems to be as specific as a highly malignant EEG in predicting poor neurologic outcome. Using these criteria significantly reduces prognostic uncertainty.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (6) , e200558
Diagnostic Yield of Next-Generation Sequencing in CSF or Brain Biopsy for Severe Encephalitis Requiring Intensive Care
The aim of this study was to evaluate the contribution of metagenomic next-generation sequencing (mNGS) in critically ill patients with encephalitis of unknown etiology. This retrospective study (2016-2023) was conducted in a tertiary care referral neuro-ICU at La Pitié-Salpêtrière Hospital (Paris, France). The inclusion criteria were encephalitis with unknown etiology and mNGS performed on CSF, brain biopsy, and/or autopsy. We assessed the yield of mNGS and whether specific treatments were initiated. Neurologic outcome at 1 year was assessed using the Glasgow Outcome Scale-Extended (GOSE-1: death; GOSE-8: upper good recovery). A total of 49 patients were included, of whom 44.9% were immunosuppressed. At 1 year, 38.8% had a GOSE score 4-8 and 47.7% died. mNGS was performed on the CSF of 40 of 49 patients (81.6%) and on brain biopsy of 19 of 49 patients (38.8%), including 12 patients who underwent both CSF and biopsy testing. Among the 40 mNGS analyses performed on the CSF, 7 (17.5%) yielded positive results but only 1 (2.5%) was likely causative. Conversely, 7 of 19 mNGS analyses (36.8%) on biopsies were positive and causative. Regarding the yield of mNGS in the entire cohort, 15 of 49 patients (30.6%) had a positive result but only 7 of 49 (14.3%) were causative (dengue virus, measles virus, rubella virus, Nocardia spp, HHV6, astrovirus, and orthobunyavirus), all from brain biopsies of immunocompromised patients. Conversely, 8 of 49 mNGS analyses (16.3%) were noncausative (polyomavirus, HHV8, HHV7, EBV, 2 pegiviruses, and 2 rhinoviruses). Specific treatments were initiated in 4 of 7 patients (57%). Among the 34 patients with a negative mNGS result, 5 (14.7%) were diagnosed with infectious encephalitis using conventional methods. In critically ill patients with encephalitis of unknown etiology, mNGS performed on brain biopsy could reduce diagnostic uncertainty.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (6) , e200558
Diagnostic Yield of Next-Generation Sequencing in CSF or Brain Biopsy for Severe Encephalitis Requiring Intensive Care
The aim of this study was to evaluate the contribution of metagenomic next-generation sequencing (mNGS) in critically ill patients with encephalitis of unknown etiology. This retrospective study (2016-2023) was conducted in a tertiary care referral neuro-ICU at La Pitié-Salpêtrière Hospital (Paris, France). The inclusion criteria were encephalitis with unknown etiology and mNGS performed on CSF, brain biopsy, and/or autopsy. We assessed the yield of mNGS and whether specific treatments were initiated. Neurologic outcome at 1 year was assessed using the Glasgow Outcome Scale-Extended (GOSE-1: death; GOSE-8: upper good recovery). A total of 49 patients were included, of whom 44.9% were immunosuppressed. At 1 year, 38.8% had a GOSE score 4-8 and 47.7% died. mNGS was performed on the CSF of 40 of 49 patients (81.6%) and on brain biopsy of 19 of 49 patients (38.8%), including 12 patients who underwent both CSF and biopsy testing. Among the 40 mNGS analyses performed on the CSF, 7 (17.5%) yielded positive results but only 1 (2.5%) was likely causative. Conversely, 7 of 19 mNGS analyses (36.8%) on biopsies were positive and causative. Regarding the yield of mNGS in the entire cohort, 15 of 49 patients (30.6%) had a positive result but only 7 of 49 (14.3%) were causative (dengue virus, measles virus, rubella virus, Nocardia spp, HHV6, astrovirus, and orthobunyavirus), all from brain biopsies of immunocompromised patients. Conversely, 8 of 49 mNGS analyses (16.3%) were noncausative (polyomavirus, HHV8, HHV7, EBV, 2 pegiviruses, and 2 rhinoviruses). Specific treatments were initiated in 4 of 7 patients (57%). Among the 34 patients with a negative mNGS result, 5 (14.7%) were diagnosed with infectious encephalitis using conventional methods. In critically ill patients with encephalitis of unknown etiology, mNGS performed on brain biopsy could reduce diagnostic uncertainty.
- Open Access
- 6 August 2025
- Published by Elsevier in Resuscitation
- Vol. 215, 110757
Degree of neurological recovery as a function of initial neuron-specific enolase levels and electroencephalographic patterns in survivors of cardiac arrest: a bicentric study
- 6 August 2025
- Published by Elsevier in Resuscitation
- Vol. 215, 110757
Open AccessDegree of neurological recovery as a function of initial neuron-specific enolase levels and electroencephalographic patterns in survivors of cardiac arrest: a bicentric study
- Open Access
- 3 July 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-7
Prognostic value of brainstem auditory evoked potentials (BAEPs) and middle latency auditory evoked potentials (MLAEPs) in unconscious patients after cardiac arrest
Assessing neurological outcome after cardiac arrest (CA) remains challenging. We aim to evaluate the prognostic value of brainstem auditory evoked potentials (BAEPs) and middle latency auditory evoked potentials (MLAEP) in patients with disorders of consciousness (DoC) after CA and indeterminate outcome according to current recommendations (i.e., no highly malignant EEG and bilateral absence of N20). A retrospective analysis was conducted using data collected prospectively from two intensive care units. The prognostic value of the absence of wave V, an abnormal conduction latency between waves III and V, an abnormal I/V amplitude ratio on BAEPs, and the absence of Na and Pa responses on MLAEPs was assessed. The primary outcome was the best Glasgow Outcome Scale-Extended (GOS-E) level within 3 months. A GOS-E level ≤ 2 (death or vegetative state) was defined as a poor outcome. 93 patients were included, 74.2% of whom were men, with a mean age of 58 years IQR [47–67]. Of these, 67/93 (72%) had a poor outcome. Unilateral absence of wave V on BAEPs was highly specific for poor outcome (Sp 96.1%), despite low sensitivity (Se 10.4%). A unilateral I/V amplitude ratio > 1 had a specificity of 87.5%, but a low sensitivity of 11.5%. Prolonged brainstem conduction time (III-V latency > 2 ms) was poorly specific for a poor outcome (Sp 70.8%). Conversely, the absence of Na and Pa on MLAEP had 100% specificity for poor outcome, with a sensitivity of 31.8%. In unconscious patients after CA with an indeterminate outcome based on neurophysiological criteria, the absence of wave V on BAEPs and the absence of Na/Pa on MLAEPs were highly specific for poor outcome, despite a low sensitivity. These results suggest that AEPs may serve as a second prognostic marker to fulfill the two-criterion requirement of the ERC/ESICM recommendations.
- 3 July 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-7
Open AccessPrognostic value of brainstem auditory evoked potentials (BAEPs) and middle latency auditory evoked potentials (MLAEPs) in unconscious patients after cardiac arrest
Assessing neurological outcome after cardiac arrest (CA) remains challenging. We aim to evaluate the prognostic value of brainstem auditory evoked potentials (BAEPs) and middle latency auditory evoked potentials (MLAEP) in patients with disorders of consciousness (DoC) after CA and indeterminate outcome according to current recommendations (i.e., no highly malignant EEG and bilateral absence of N20). A retrospective analysis was conducted using data collected prospectively from two intensive care units. The prognostic value of the absence of wave V, an abnormal conduction latency between waves III and V, an abnormal I/V amplitude ratio on BAEPs, and the absence of Na and Pa responses on MLAEPs was assessed. The primary outcome was the best Glasgow Outcome Scale-Extended (GOS-E) level within 3 months. A GOS-E level ≤ 2 (death or vegetative state) was defined as a poor outcome. 93 patients were included, 74.2% of whom were men, with a mean age of 58 years IQR [47–67]. Of these, 67/93 (72%) had a poor outcome. Unilateral absence of wave V on BAEPs was highly specific for poor outcome (Sp 96.1%), despite low sensitivity (Se 10.4%). A unilateral I/V amplitude ratio > 1 had a specificity of 87.5%, but a low sensitivity of 11.5%. Prolonged brainstem conduction time (III-V latency > 2 ms) was poorly specific for a poor outcome (Sp 70.8%). Conversely, the absence of Na and Pa on MLAEP had 100% specificity for poor outcome, with a sensitivity of 31.8%. In unconscious patients after CA with an indeterminate outcome based on neurophysiological criteria, the absence of wave V on BAEPs and the absence of Na/Pa on MLAEPs were highly specific for poor outcome, despite a low sensitivity. These results suggest that AEPs may serve as a second prognostic marker to fulfill the two-criterion requirement of the ERC/ESICM recommendations.
- Open Access
- 30 May 2025
- Published by Elsevier in Annals of Intensive Care
- Vol. 15 (1) , 75-13
Absolute blood levels and kinetics of neurofilament light (NFL) chains for neurological prognosis in comatose patients after cardiac arrest
- 30 May 2025
- Published by Elsevier in Annals of Intensive Care
- Vol. 15 (1) , 75-13
Open AccessAbsolute blood levels and kinetics of neurofilament light (NFL) chains for neurological prognosis in comatose patients after cardiac arrest